Clin2
NCT06881810Possibly a fitActive, not recruiting

Oxytocin for social skills in schizophrenia

Schizophrenia Spectrum Disorders (SSD)

Treatments studied

Part of Mental health clinical trials.

This trial tests if adding oxytocin (a hormone that helps with social bonding) to regular therapy can improve social skills in people with schizophrenia or related disorders. You must have some negative symptoms (like lack of motivation or social withdrawal) and be in treatment at least twice a week.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
98 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are between 18 and 64 years old.
  • You have been diagnosed with schizophrenia or a similar disorder.
  • You have at least one negative symptom (like lack of interest in people or difficulty speaking) that is moderate or worse.
  • You are receiving regular psychosocial treatment (therapy or support) at least twice a week.
  • If you are a woman who can become pregnant, you must use a highly effective birth control method.
  • You cannot have a severe substance use disorder (other than nicotine) or be in coercive treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07265180Recruiting
Oxytocin and group therapy for schizophrenia

This trial tests whether adding oxytocin (a hormone that helps with social bonding) to group therapy can improve symptoms and social functioning in people with schizophrenia. It compares two different doses of oxytocin to see which works better.

Berlin, State of Berlin
NCT07742124Recruiting
Oxytocin nasal spray for postmenopausal women

This study tests whether an oxytocin nasal spray affects social behavior and hormones in postmenopausal women. Being postmenopausal may change how the body responds to oxytocin, so this research aims to see if it can help with mood or social connections.

Basel, Canton of Basel-City
NCT06676774Recruiting· Phase 2
Does oxytocin nasal spray help people with diabetes insipidus?

This study tests if a nasal spray with oxytocin (a natural hormone) can improve emotion recognition and reduce stress-related hormone levels in people with central diabetes insipidus compared to healthy volunteers.

Basel
NCT06808516Recruiting· Phase 2
Can oxytocin spray improve sex life in people with AVP deficiency?

This study tests whether a nasal spray containing oxytocin can improve sexual well-being in people with a condition called arginine vasopressin deficiency (a problem with a hormone that controls water balance). Healthy volunteers who have mild sexual issues will also take part for comparison. Participants receive either the oxytocin spray or a placebo and fill out questionnaires about their sex life.

Basel
NCT06248710Recruiting· Phase 2/Phase 3
Dog presence and oxytocin spray for trust in therapy

This study explores whether being with a friendly dog and getting a nasal spray of oxytocin (a natural hormone) can help you feel more trust toward a therapist. It's looking for healthy adults who are comfortable around dogs.

Basel, Canton of Basel-City
NCT07555132Not yet recruiting
MDMA and Oxytocin Changes in Autism and Healthy Adults

This study tests whether a drug called MDMA changes oxytocin levels (a hormone related to social bonding) differently in autistic adults compared to non-autistic adults. Researchers want to understand if MDMA might help with social challenges some autistic people experience.

Basel

Hear when a new Schizophrenia Spectrum Disorders (SSD) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.